STING1 and small cell lung carcinoma: Ataxia telangiectasia and rad3 related inhibitors trigger STING-dependent interferon signaling and up-regulate MHC-I, sensitizing SCLC to PD-L1 blockade in pre-clinical models and patient specimens (182).